Search

everythinglearnresearchcommunity

for

Search:↓

More research is needed to confirm if vitamin D helps improve pregnancy rates in women with hyperandrogenic PCOS.

Most pregnant women experience skin changes, with hyperpigmentation being the most common.

Pregnancy can cause various skin changes, with stretch marks, dark lines on the abdomen, and skin darkening being the most common.

Pregnant women often have skin changes, but only a small percentage have skin conditions caused by or specific to pregnancy; doctors need to tell them apart for proper treatment.

Pregnant women often experience various skin changes, with pigment changes and stretch marks being most common.

Topical treatment is recommended for Folliculitis decalvans in pregnant women.

Women with androgenetic alopecia often have other symptoms of high androgen levels, requiring further hormone testing.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Isotretinoin can safely and effectively control acne with proper risk management and monitoring.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

Platelet-rich plasma may help improve atopic dermatitis symptoms and quality of life.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

Older age, higher BMI, and family history of diabetes increase the risk of gestational diabetes in pregnant women.

Hair loss after childbirth is more common in women who have had multiple births, cesarean deliveries, significant weight gain, and full-term pregnancies.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Imipramine and pseudoephedrine treatment can effectively restore normal ejaculation in patients with diabetes, increasing their chances for pregnancy.

Stopping the pill and giving birth both caused hair loss.

A woman's increased hair growth during pregnancy due to PCOS resolved after delivery.

Pregnant and breastfeeding women should get COVID-19 vaccines for safety and protection.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Certain health factors can worsen fertility treatment results in women with PCOS.

A pregnant woman with Werner's syndrome died during childbirth, but her baby survived and did not have the syndrome.

The combination therapy effectively treats infertility in PCOS without major side effects.

Most pregnant women experience skin changes, especially increased pigmentation.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).